Despite improvements to treatments for HCV infection, almost half of patients cannot be
cured with standard combination therapy (pegylated interferon α and ribavirin). The HCV life …

Background The efficacy of treatment against hepatitis C virus has improved, but it is still far
from ideal. Thus, new antihepatitis C virus therapies are required. Aim To evaluate the data …

Although many of the agents reviewed are in the early stages of development they show
great promise and the ever-increasing understanding of hepatitis C virus will undoubtedly …